View more on these topics

Neil Woodford launches fresh attack on GlaxoSmithKline

Neil Woodford New 620x430

Neil Woodford has criticised GlaxoSmithKline chief executive Andrew Witty and called for a radical shake-up of the pharmaceutical giant.

Speaking at the AJ Bell Investival conference in London yesterday, the star fund manager said: “Glaxo has been a very disappointing investment for me for a very long time and the hopes that I had for that business have really been dashed over the years.”

He added: “I think the corporate structure is wrong, I think the business needs to focus on one or two of the businesses that it has in its portfolio at the moment.”

Woodford has previously urged GSK to split up to reassure shareholders on the firm’s profitability.

Woodford said: “I think the company should focus on what it ought to do well, which is basically pharmaceuticals and vaccines and I think it should spin or sell its consumer healthcare business and that is what I’ve been saying for a long time.”

Since 2008, GSK has been focusing on vaccines and consumer products rather than on highly priced prescription drugs, believing the strategy would bring more returns.

Woodford said: “You know as much as I do that running a FTSE 100 company is a very challenging business. In essence, Andrew Witty is running four FTSE 100 companies and he’s not doing a very good job in my view.”

The manager is pushing GSK to explore a formal separation of the HIV business ViiV, the company consumer healthcare division and Stiefel, its dermatology division, from the firm’s core medicines and vaccines unit.

However, despite his disappointment, Woodford said he retained GSK in his portfolio as he believes there is “a huge unlocked value in the business”, and has also recently increased his allocation in the company.

As of the end of September, the £7.07bn CF Woodford Equity Income fund held 6.12 per cent of the fund in GSK.



‘No evidence’ HMRC rules are cleaning up SSAS market

SSAS savers are still at risk of tax charges a year on from the introduction of fit and proper rules designed to protect against scams, providers warn. Since 1 September 2014, HM Revenue & Customs has been able to refuse both to register a new  pension scheme and to de-register an existing scheme if the scheme’s administrator […]


Tyrie tells regulators to resist bank lobbying

Treasury select committee chair Andrew Tyrie has warned regulators to stand firm in the face of a lobbying drive by banks to water down regulation. The Financial Times reports a speech made by Tyrie in the City of London last night where the MP argued that banks should not be able to circumvent new ringfencing […]

Ros Altmann

Now: Pensions in ‘catch 22’ over Govt tax relief stance

Now: Pensions says it is caught in a  “catch 22” after the pensions minister warned employers against its chosen tax relief model. This week Ros Altmann wrote to The Pensions Regulator asking it to warn employers that providers using a ‘net pay’ arrangement do not allow people earning under £10,600 to claim tax relief on their contributions. […]


FCA blasted over inability to fine HBOS execs

The FCA has been slammed after it admitted it was unable to fine any former HBOS executives over the bank’s collapse during the financial crisis. The regulator’s HBOS report is to be published later this week. It is expected to include a lengthy examination of why only one HBOS director, Peter Cummings, was fined in […]


DB transfer shouldn’t be all-or-nothing

By Steve Webb, director of policy In my recent discussions with advisers, a hot topic has been the growing number of people interested in transferring their defined benefit pension rights into a defined contribution pension scheme. With many pension schemes offering eye-watering transfer values, this is likely to be an area of increasing interest. Yet […]


News and expert analysis straight to your inbox

Sign up


There are 2 comments at the moment, we would love to hear your opinion too.

  1. Is it not the job of fund managers to select companies which it believes are going to perform well in the current and future environment? Instead of this Mr Woodford seeks to buys shares and instigate the entire corporate re-structure of a global giant! Megalomaniac tendencies perhaps in evidence????
    I would be asking questions of the mangers decision making if I invested in his fund.

  2. It takes a brave man or woman to have a pop at Neil Woodford.

    I think it is the job of large institutional investors to exert pressure on those at the top of giant companies so many rely on, either knowingly through actively investing or by simply holding index trackers, to deliver their future income and prosperity. Individual shareholders certainly cannot do so.

Leave a comment


Why register with Money Marketing ?

Providing trusted insight for professional advisers.  Since 1985 Money Marketing has helped promote and analyse the financial adviser community in the UK and continues to be the trusted industry brand for independent insight and advice.

News & analysis delivered directly to your inbox
Register today to receive our range of news alerts including daily and weekly briefings

Money Marketing Events
Be the first to hear about our industry leading conferences, awards, roundtables and more.

Research and insight
Take part in and see the results of Money Marketing's flagship investigations into industry trends.

Have your say
Only registered users can post comments. As the voice of the adviser community, our content generates robust debate. Sign up today and make your voice heard.

Register now

Having problems?

Contact us on +44 (0)20 7292 3712

Lines are open Monday to Friday 9:00am -5.00pm